Psychiatry and Neurology, Neurology · Indianapolis, IN
NPI
1346264892
Since 2006
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
550 University Blvd
Indianapolis, IN, 46202
Phone (317) 274-8800
Groups this clinician bills Medicare through
Medicare paid, 2024
$18K
287 services
Medicare patients, 2024
151
Average age 71
Drug cost, 2024
$2.1M
734 prescriptions
Company payments, 2025
$77.75
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by John C Kincaid was code 99213 (office e&m - established), 122 times for 89 patients. In total John C Kincaid billed 287 services in 23 codes, and Medicare paid $18K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-01-13.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 122 | 89 | $58.20 | $7,100 |
| 95885 Electrical Nerve Conductivity | Office | 45 | 32 | $41.81 | $1,881 |
| 95908 Electrical Nerve Conductivity | Office | 21 | 21 | $82.02 | $1,722 |
| 95886 Electrical Nerve Conductivity | Office | 17 | 16 | $70.50 | $1,199 |
By year: 2022 $26K for 369 services; 2023 $21K for 341 services; 2024 $18K for 287 services.
Medicare prescription drug claims, 2024
In 2024, the drug John C Kincaid prescribed most often to Medicare patients was Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen), with 86 prescriptions and refills. In total John C Kincaid wrote 734 Medicare prescriptions that cost $2.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 86 | 86 | 11 | $2,129 |
| Prednisone Generic | 69 | 131 | 12 | $1,070 |
| Gabapentin Generic | 63 | 98 | 12 | $1,874 |
| Topiramate Generic | 37 | 92 | Under 11 | $687 |
| Diazepam Generic | 31 | 47 | Under 11 | $282 |
| Carbamazepine Generic | 28 | 71 | Under 11 | $3,025 |
| Gamunex-C Immune Globul G/Gly/Iga Avg 46 | 28 | 39 | Under 11 | $114K |
| Hizentra Immun Glob G(Igg)/Pro/Iga 0-50 | 26 | 26 | Under 11 | $935K |
| Pyridostigmine Bromide Generic | 24 | 44 | Under 11 | $1,967 |
| Mycophenolate Mofetil Generic | 24 | 34 | Under 11 | $2,605 |
| Propranolol Hcl Generic | 23 | 53 | Under 11 | $433 |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 22 | 22 | Under 11 | $616 |
| Azathioprine Generic | 19 | 47 | Under 11 | $1,672 |
| Gammaplex Immun Glob G(Igg)/Gly/Iga 0-50 | 18 | 18 | Under 11 | $480K |
| Sodium Chloride 0.9 % Sodium Chloride | 13 | 13 | Under 11 | $47.58 |
Brand drugs: 147 claims; generic drugs: 587 claims; opioid claims: 162.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid John C Kincaid $77.75 ($77.75 in general payments such as food, travel and fees) from 1 company. The largest payer was Alexion Pharmaceuticals, Inc. with $77.75.
| Company | Payments | Amount |
|---|---|---|
| Alexion Pharmaceuticals, Inc. AZN | 1 | $77.75 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.